The versions affected are called compounded medications, which have the same active ingredients as the name brands. The restrictions began because the FDA declared a shortage of tirzepatide, often ...

Zepbound is a newer weight loss medication joining the ranks of Wegovy and Saxenda. It’s a brand name for tirzepatide, which manufacturers also sell as a drug for type 2 diabetes under the name ...

Iuliia Burmistrova/Getty Images The FDA has ordered compounding pharmacies to stop making less expensive versions of popular weight loss medications like Ozempic and Zepbound. The order comes ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.5% in the afternoon session after the company revealed it will offer Eli Lilly's weight-loss medications (Zepbound ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no ... often found on drug manufacturers' websites, to help lower the cost, according to ...

Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

It stands out as one of the best growth stocks, boasting a robust pipeline of diabetes and weight loss drugs. Its GLP-1-approved drugs in Zepbound ... billion in four new manufacturing locations ...

These branded prescription pharmaceuticals – approved by the Food and Drug Administration – are so popular and in demand that pharmaceutical manufacturers could not keep up with production.

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro.

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...

In a key secondary endpoint, 31.6% of people taking tirzepatide achieved at least 25% body weight loss ... in manufacturing capacity at both companies. GlobalData recently predicted that Zepbound ...